References
[1] M. Petersen, M.S.J. Simmonds, Rosmarinic acid., Phytochemistry. 62 (2003) 121–5. https://doi.org/10.1016/s0031-9422(02)00513-7.
[2] J. WEIZHE, J. MINJIE, L. QING, Rosemary acid derivative, preparation method and application, CN110563602A, 2019. https://doi.org/10.1007/s11033-020-05447-x.
[3] P.R. Omar, T.R. Irma, M.D. Maricela, E.M. Abraham, P.U. José, Pharmacokinetic noninteraction analysis in a fixed-dose formulation in combination of atorvastatin and ezetimibe, Front. Pharmacol. 5 (2014) 1–9. https://doi.org/10.3389/fphar.2014.00261.
[4] R. Liu, E.H. Heiss, B. Waltenberger, T. Blazevic, D. Schachner, B. Jiang, V. Krystof, W. Liu, S. Schwaiger, L.M. Pena-Rodriguez, J.M. Breuss, H. Stuppner, V.M. Dirsch, A.G. Atanasov, Constituents of Mediterranean Spices Counteracting Vascular Smooth Muscle Cell Proliferation: Identification and Characterization of Rosmarinic Acid Methyl Ester as a Novel Inhibitor., Mol. Nutr. Food Res. 62 (2018) e1700860. https://doi.org/10.1002/mnfr.201700860.
[5] J. Min, H. Chen, Z. Gong, X. Liu, T. Wu, W. Li, J. Fang, T. Huang, Y. Zhang, W. Zhao, C. Zhu, Q. Wang, S. Mi, N. Wang, Pharmacokinetic and Pharmacodynamic Properties of Rosmarinic Acid in Rat Cholestatic Liver Injury., Molecules. 23 (2018). https://doi.org/10.3390/molecules23092287.
[6] P. Lin, Y. Dai, Z. Yao, Z. Qin, L. He, Q. Wang, Z. Wei, Y. Zhang, X. Yao, Metabolic profiles and pharmacokinetics of Qingre Xiaoyanning capsule, a traditional Chinese medicine prescription of Sarcandrae Herba, in rats by UHPLC coupled with quadrupole time-of-flight tandem mass spectrometry., J. Sep. Sci. 42 (2019) 784–796. https://doi.org/10.1002/jssc.201800981.
[7] Y. Yang, S. Ying, T. Li, J. Zhen, D. Chen, J. Wang, A sensitive LC-MS/MS-based bioanalytical method for quantification of salviaflaside and rosmarinic acid in rat plasma and its application in a pharmacokinetic study., Biomed. Chromatogr. 32 (2018) e4259. https://doi.org/10.1002/bmc.4259.
[8] J. Baranauskaite, G. Duman, G. Corapcioglu, A. Baranauskas, A. Taralp, L. Ivanauskas, J. Bernatoniene, Liposomal Incorporation to Improve Dissolution and Stability of Rosmarinic Acid and Carvacrol Extracted from Oregano (O. onites L.)., Biomed Res. Int. 2018 (2018) 6147315. https://doi.org/10.1155/2018/6147315.
[9] Y. Li, D. Yang, C. Zhu, Impact of Sodium N-[8-(2-Hydroxybenzoyl)amino]-caprylate on Intestinal Permeability for Notoginsenoside R1 and Salvianolic Acids in Caco-2 Cells Transport and Rat Pharmacokinetics., Molecules. 23 (2018). https://doi.org/10.3390/molecules23112990.
[10] H.-Z. Ouyang, J. He, Simultaneous determination of nine constituents of Xuebijing Injection in rat plasma and their pharmacokinetics by LC-MS/MS., Zhongguo Zhong Yao Za Zhi. 43 (2018) 3553–3561. https://doi.org/10.19540/j.cnki.cjcmm.20180611.010.
[11] P. Lu, Y. Xing, Z. Xue, Z. Ma, B. Zhang, H. Peng, Q.T. Zhou, H. Liu, Z. Liu, J. Li, Pharmacokinetics of salvianolic acid B, rosmarinic acid and Danshensu in rat after pulmonary administration of Salvia miltiorrhiza polyphenolic acid solution., Biomed. Chromatogr. 33 (2019) e4561. https://doi.org/10.1002/bmc.4561.
[12] J. WEIZHE, J. MINJIE, L. QING, Rosemary acid derivative, preparation method and application, CN110563602A, 2019.
[13] J.-H. Yang, K.-J. Mao, P. Huang, Y.-J. Ye, H.-S. Guo, B.-C. Cai, Effect of piperine on the bioavailability and pharmacokinetics of rosmarinic acid in rat plasma using UPLC-MS/MS., Xenobiotica. 48 (2018) 178–185. https://doi.org/10.1080/00498254.2017.1292564.
[14] M. Noguchi-Shinohara, K. Ono, T. Hamaguchi, K. Iwasa, T. Nagai, S. Kobayashi, H. Nakamura, M. Yamada, Pharmacokinetics, safety and tolerability of Melissa officinalisextract which contained rosmarinic acid in healthy individuals: A randomized controlled trial, PLoS One. 10 (2015) 1–13. https://doi.org/10.1371/journal.pone.0126422.
Fig. 1. Chemical structures of RA (A), A1 (B) and PPD (C).
Fig. 2. Precursor ion and product ion spectra of RA (a), A1 (b) and PPD (c).
Fig. 3. Characterization of the analyte fragments. (a) m/z 359 → 161 for RA; (b) m/z 358 → 161 for A1; and (c) m/z 164 → 146 for PPD.
Fig. 4. Representative SRM chromatograms of PPD (IS, I), RA (II) and A1 (III) in rat plasma: (a) a blank rat plasma sample; (b) a blank rat plasma sample spiked with PPD (100 ng/ml), RA (10 ng/ml), and A1 (10 ng/ml); (C) a rat plasma sample 30 min after an oral dose of RA and A1 was administered at 10 mg/kg (calculated as RA) to a Sprague–Dawley rat.
Fig. 5. Mean plasma concentration–time profiles of RA and A1 administered to 12 Sprague–Dawley rats (mean ± SD).